Literature DB >> 1087215

A subpopulation of human B lymphocytes that rosette with mouse erythrocytes.

I J Forbes, P D Zalewski.   

Abstract

A proportion of human peripheral blood lymphocytes form rosettes with mouse erythrocytes (M-RFC). It is confirmed that the proportion of such rosette-forming cells is high in chronic lymphocytic leukaemia (CLL). Analysis of normal lymphocyte populations revealed that M-RFC belong to the B-lymphocyte subclass exclusively. Analysis of their surface markers showed: (a) complement receptors in 50% as compared to 71% of the total B-cell population; (b) a distribution of surface immunoglobulins G, A, M and E typical of the lymphocyte sources; (c) lack of sheep erythrocyte receptor. No differences in the ratio of M-RFC to total B cells was found between lymphocyte population from tonsils, bone marrow and peripheral blood although a significantly higher ratio was seen in cord blood and in chronic lymphocytic leukaemia. Investigation of the properties of mouse erythrocyte rosette formation revealed the following: (a) incubation of lymphocyte mouse erythrocyte mixtures at 37degreesC before centrifugation inhibited rosette formation when CLL lymphocytes were used; (b) treatment of mouse erythrocytes with neuraminidase or trypsin increased their adhesiveness to lymphocytes; (c) treatment of lymphocytes with neuraminidase promoted M-rosette formation but trypsin treatment had an inhibitory effect; (d) cyanide and fluoride at concentrations which strongly inhibited E-rosette formation had no inhibitory effect on M rosettes; (e) M-rosette formation was inhibited by anti-immunoglobulin serum but not by anti-lymphocyte serum; and (f) M-rosette formation was also inhibited by the presence of staphylococci. E-rosette formation was unaffected. The nature of the bond in mouse rosettes is discussed in the light of these findings. The evidence indicates that the lymphocyte receptor may be a part of an immunoglobulin molecule.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087215      PMCID: PMC1540811     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Formation of mouse red cell rosettes by "hairy" cells.

Authors:  D Catovsky; M Papamichail; A Okos; E Miliani; E J Holborow
Journal:  Biomedicine       Date:  1975-04-10

2.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

3.  Mode of action for anti-lymphocyte serum.

Authors:  E Leuchars; V J Wallis; A J Davies
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

4.  Electron microscopic study of the lymphocytes capable of binding antigen-antibody-complement complexes.

Authors:  L T Chen; A Eden; V Nussenzweig; L Weiss
Journal:  Cell Immunol       Date:  1972-07       Impact factor: 4.868

5.  In vivo specific antigen recognition by rosette forming cells.

Authors:  J F Bach; J Y Muller; M Dardenne
Journal:  Nature       Date:  1970-09-19       Impact factor: 49.962

6.  Phylogenetic insight into evolution of mammalian Fc fragment of gamma G globulin using staphylococcal protein A.

Authors:  G Kronvall; U S Seal; J Finstad; R C Williams
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

7.  A scanning and transmission electron microscope study of antigen-binding sites on rosette-forming cells.

Authors:  F G Gudat; W Villiger
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

8.  Electron microscope study of surface immunoglobulin-bearing human tonsil cells.

Authors:  D Zucker-Franklin; S Berney
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

9.  The total N-acetyl neuraminic acid content of human normal and lymphatic leukaemic lymphocytes.

Authors:  D A McClelland; J M Bridges
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

  9 in total
  23 in total

1.  beta-D-N-acetylglucosaminidase, a new cytochemical marker of human lymphocyte subpopulations.

Authors:  E Orye; Y Benoit; L Roesbeke; M De Wilde; M Van Yper
Journal:  Histochemistry       Date:  1985

2.  Surface marker and other characteristics of Gaucher's cells.

Authors:  G F Burns; J C Cawley; R J Flemans; K E Higgy; C P Worman; C R Barker; B E Roberts; F G Hayhoe
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

3.  Cell surface differentiation of acute lymphoblastic call-type leukemias in diffusion chambers.

Authors:  G Jäger; B Lau; K Pachmann; H Rodt; B Netzel; E Thiel; D Huhn; S Thierfelder; P Dörmer
Journal:  Blut       Date:  1979-02-19

4.  B-cell lymphoma lacking Fc- and C3d-receptors.

Authors:  E Thiel
Journal:  Blut       Date:  1978-12-15

5.  Studies of the human lymphocyte-mouse erythrocyte bond.

Authors:  P D Zalewski; I J Forbes
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Rosette-formation with mouse red blood cells in chronic lymphocytic leukemia and leukemic non-Hodgkin's lymphomas.

Authors:  R Wirthmüller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1980-07-15

7.  Appearance of B- or T-lymphocyte markers after diffusion chamber culture of acute lymphoblastic leukemia cells.

Authors:  E Thiel; B Lau; H Rodt; G Jäger; K Pachmann
Journal:  Blut       Date:  1981-05

8.  Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.

Authors:  E Kuhlein; G Laurent; F Rigal; G Delsol; J Pris; J Ducos
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  B lymphocyte specificity of lectins of Cepaea nemoralis and Dolichos biflorus: paradoxical binding of anti-A active lectins to human lymphocyte subclasses.

Authors:  P D Zalewski; I J Forbes; G Uhlenbruck; L Valente
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

10.  Mouse red blood cell rosettes: human B and some T lymphocytes express receptors for mouse erythrocytes in the presence of Ficoll.

Authors:  O Eremin; R M Binns
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.